Literature DB >> 16054303

Circulation DNA: biological implications for cancer metastasis and immunology.

Z Chen1, A Fadiel, F Naftolin, K D Eichenbaum, Y Xia.   

Abstract

Circulation cell free DNA (cf-DNA) is of considerable interest to oncology researchers seeking to isolate specific cancer markers. Here, we focus on the origin and biological implications of cf-DNA, exploring its potential roles in cancer biology and medicine. We hypothesize that cf-DNA is primarily released by living cancer cells in addition to apoptotic or necrotic cancer cells for three reasons: (1) following radiotherapy, cf-DNA quantities are significantly reduced in a high percentage of patients although radiation-induced massive apoptosis is expected; (2) cancer cell DNA concentration in cultured supernatants increases with cell proliferation when few apoptotic or necrotic cells are present; and (3) DNA concentration increases in normal lymphocyte cultures following stimulation with phytohemagglutinin, lipopolysaccharide or antigen. Our hypotheses have major biological implications in cancer biology. First, cancer cf-DNA may transform normal cells and form adjacent or remote metastases or second primary cancer. In this context, we also have raised an alarming advice that the cancer may be potentially infectious. Secondly, if a normal cf-DNA contains cytokine sequence, it may behave like an intrinsic DNA vaccine, producing therapeutic cytokine. If normal cf-DNA contains a sequence of a non-mutated oncogene or tumor suppressor gene, homologous recombination with the cancer genome may occur leading to knock out mutated oncogene or tumor suppressor gene that could thus elicit a spontaneous remission of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054303     DOI: 10.1016/j.mehy.2005.04.042

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  14 in total

1.  Getting to know the fetal genome non-invasively: now a reality.

Authors:  Maulik M Dhandha
Journal:  Protein Cell       Date:  2012-10       Impact factor: 14.870

2.  Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.

Authors:  Li Gao; Erfu Xie; Tongfu Yu; Dan Chen; Lixia Zhang; Bingfeng Zhang; Fang Wang; Jian Xu; Peijun Huang; Xisheng Liu; Bingliang Fang; Shiyang Pan
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Circulating nucleic acids: An analysis of their occurrence in malignancies.

Authors:  Shankar Suraj; Chirag Dhar; Sweta Srivastava
Journal:  Biomed Rep       Date:  2016-11-16

Review 4.  The Influence of Proteins on Fate and Biological Role of Circulating DNA.

Authors:  Oleg Tutanov; Svetlana Tamkovich
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 5.  The role of extracellular DNA (exDNA) in cellular processes.

Authors:  Ileana J Fernández-Domínguez; Joaquin Manzo-Merino; Lucia Taja-Chayeb; Alfonso Dueñas-González; Enrique Pérez-Cárdenas; Catalina Trejo-Becerril
Journal:  Cancer Biol Ther       Date:  2021-04-16       Impact factor: 4.742

6.  Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.

Authors:  István Fűri; Alexandra Kalmár; Barnabás Wichmann; Sándor Spisák; Andrea Schöller; Barbara Barták; Zsolt Tulassay; Béla Molnár
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

7.  Increased plasma cell-free DNA level during HTNV infection: correlation with disease severity and virus load.

Authors:  Jing Yi; Yun Zhang; Yusi Zhang; Ying Ma; Chunmei Zhang; Qi Li; Bei Liu; Zhijia Liu; Jiayun Liu; Xianqing Zhang; Ran Zhuang; Boquan Jin
Journal:  Viruses       Date:  2014-07-15       Impact factor: 5.048

8.  Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.

Authors:  Inessa Skrypkina; Liudmyla Tsyba; Kateryna Onyshchenko; Dmytro Morderer; Olena Kashparova; Oleksii Nikolaienko; Grigory Panasenko; Sergii Vozianov; Alina Romanenko; Alla Rynditch
Journal:  Dis Markers       Date:  2016-09-20       Impact factor: 3.434

9.  Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.

Authors:  Ludmila A Alekseeva; Nadezhda L Mironova; Evgenyi V Brenner; Alexander M Kurilshikov; Olga A Patutina; Marina A Zenkova
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

10.  Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.

Authors:  Max Schreuer; Geert Meersseman; Sari Van Den Herrewegen; Yanina Jansen; Ines Chevolet; Ambre Bott; Sofie Wilgenhof; Teofila Seremet; Bart Jacobs; Ronald Buyl; Geert Maertens; Bart Neyns
Journal:  J Transl Med       Date:  2016-04-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.